Binding of labelled influenza matrix peptide to HLA DR in living B lymphoid cells

No abstract is available for this paper.

• Publication year

  1989

• Venue

  Nature

• Publication date

  1989-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/339392A0PMID 2786148
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Human helper T-cell clones that recognize different influenza hemagglutinin determinants are restricted by different HLA-D region epitopes

  2004cited by this paper
• Antigen processing and intracellular Ia. Possible roles of endocytosis and protein synthesis in Ia function.

  1989cited by this paper
• Structural model of HLA-DR1 restricted T cell antigen recognition.

  1988cited by this paper
• Kinetics of MHC-antigen complex formation on antigen-presenting cells.

  1988cited by this paper
• Binding of photoreactive lysozyme peptides to murine histocompatibility class II molecules.

  1988cited by this paper
• Autologous peptides constitutively occupy the antigen binding site on Ia.

  1988cited by this paper
• Identification of a peptide binding protein that plays a role in antigen presentation.

  1987cited by this paper
• Isolation and characterization of antigen-Ia complexes involved in T cell recognition.

  1986cited by this paper
• High-affinity fluorescent peptide binding to I-Ad in lipid membranes.

  1986cited by this paper
• Interaction of peptide antigens and class II major histocompatibility complex antigens

  1986cited by this paper
• Internalization of lymphocyte membrane components.

  1985cited by this paper
• Cell Surface Receptors: A Short Course on Theory and Methods

  1985cited by this paper
• Binding of immunogenic peptides to Ia histocompatibility molecules

  1985cited by this paper
• Antigen recognition by H-2-restricted T cells. II. A tryptic ovalbumin peptide that substitutes for processed antigen.

  1984cited by this paper
• Macrophage processing of peptide antigens: identification of an antigenic complex.

  1984cited by this paper
• Antigen recognition by H-2-restricted T cells. I. Cell-free antigen processing

  1983cited by this paper
• Quantitative analysis of cell surface HLA structures by means of monoclonal antibodies.

  1980cited by this paper
• Murine Monoclonal Antibodies against HLA Structures

  1979cited by this paper
• Studies on Peptides. XLVIII. Application of the Trifluoromethanesulphonic Acid Procedure to the Synthesis of Tuftsin

  1975cited by this paper
• THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY.

  1963cited by this paper
• Solid phase peptide synthesis. I. the synthesis of a tetrapeptide

  1963cited by this paper

• Genetic variability in LMP2 and LMP7 is associated with the risk of esophageal squamous cell carcinoma in the Kazakh population but is not associated with HPV infection

  2017cites this paper
• Characterization of desmoglein‐3 epitope region peptides as synthetic antigens: analysis of their in vitro T cell stimulating efficacy, cytotoxicity, stability, and their conformational features

  2015cites this paper
• Modern Subunit Vaccines: Development, Components, and Research Opportunities

  2013cites this paper
• Measurement of MHC/Peptide Interactions by Gel Filtration or Monoclonal Antibody Capture

  2013cites this paper
• APC Influences T Cell Recognition Peptide Endocytosis and Reduction Within Cysteinylation of MHC Class II Ligands

  2013cites this paper
• Lack of association between the unique LMP2 gene polymorphism and the outcome of lung cancer in a population of Chinese Han nationality.

  2012cites this paper
• Direct binding of thymopentin to surface class II major histocompatibility complex in living cells.

  2010cites this paper
• Supertypic Binding Specificity Population Share a Common HLA Expressed in the Worldwide Human Five HLA-DP Molecules Frequently

  2010cites this paper
• Five HLA-DP Molecules Frequently Expressed in the Worldwide Human Population Share a Common HLA Supertypic Binding Specificity

  2010cites this paper
• Human leukocyte antigen‐DRB1*1101 correlates with less severe hepatitis in Taiwanese male carriers of hepatitis B virus

  2009cites this paper
• Human monoclonal antibody with T-cell-like specificity recognizes MHC class I self-peptide presented by HLA-DR1 on activated cells.

  2008cites this paper
• Microbial carbohydrate depolymerization by antigen-presenting cells: Deamination prior to presentation by the MHCII pathway

  2008cites this paper
• Molecular Analysis of Thymopentin Binding to HLA-DR Molecules

  2007cites this paper
• Albumin binding to FcRn: distinct from the FcRn-IgG interaction.

  2006cites this paper
• Identification and biochemical characterization of a novel receptor:ligand interaction between FcRn and albumin

  2005cites this paper
• Factors limiting the immunogenicity of HIV-1 gp120 envelope glycoproteins.

  2004cites this paper
• Normal HBsAg presentation and T-cell defect in the immune response of nonresponders

  2004cites this paper
• Association of the HLA-DRB1 gene locus with gastric adenocarcinoma in Japan.

  2003cites this paper
• HLA class I B44 is associated with sustained response to interferon + ribavirin therapy in patients with chronic hepatitis C

  2003cites this paper
• Association between HLA class II antigens and hepatitis C virus infection.

  2003cites this paper
• Association of HLA Alleles with Response (Especially Biochemical Response) to Interferon Therapy in Japanese Patients with Chronic Hepatitis C

  2003cites this paper
• Complex Carbohydrates Are Not Removed During Processing of Glycoproteins by Dendritic Cells

  2002cites this paper
• A single nucleotide polymorphism of the low molecular mass polypeptide 7 gene influences the interferon response in patients with chronic hepatitis C

  2002cites this paper
• Inhibition of T cell responses by transferrin-coupled competitor peptides

  2002cites this paper
• Cysteinylation of MHC Class II Ligands: Peptide Endocytosis and Reduction Within APC Influences T Cell Recognition1

  2001cites this paper
• Characterization of hepatitis B virus surface antigen‐specific CD4+ T cells in hepatitis B vaccine non‐responders

  2001cites this paper
• Human leukocyte antigen DRB1 1302 protects against bile duct damage and portal lymphocyte infiltration in patients with chronic hepatitis C.

  2000cites this paper
• Endocytic Recycling is Required for the Presentation of an Exogenous Peptide via MHC Class II Molecules

  2000cites this paper
• The humoral immune response against an HLA class I allodeterminant correlates with the HLA-DR phenotype of the responder.

  1999cites this paper
• Measurement of MHC/Peptide Interactions by Gel Filtration

  1999cites this paper
• Influence of HLA haplotypes on the clinical courses of individuals infected with hepatitis C virus

  1998influential citation
• Development of peptide vaccines inducing production of neutralizing antibodies against HIV-1 viruses in HLA-DQ6 mice.

  1998cites this paper
• Inefficient peptide binding by cell-surface class II MHC molecules.

  1997cites this paper
• Measuring the capacity of peptides to bind class II MHC molecules and act asTCR antagonists

  1996cites this paper
• Increased frequency of HLA DR13 in hepatitis C virus carriers with persistently normal ALT levels

  1996cites this paper
• Homeostatic regulation of CD8+ T cells after antigen challenge in the absence of Fas (CD95)

  1996cites this paper
• Conformation of Human Leukocyte Antigen Class II Molecules

  1996cites this paper
• DM enhances peptide binding to class II MHC by release of invariant chain-derived peptide.

  1995cites this paper
• Stimulation of T cells by antigen-presenting cells is kinetically controlled by antigenic peptide binding to major histocompatibility complex class II molecules.

  1995cites this paper
• 12 – Synthesis and Applications of Branched Peptides in Immunological Methods and Vaccines

  1995cites this paper
• The human immune response to hepatitis B surface antigen.

  1995cites this paper
• Differential antigen presentation of hepatitis B surface antigen on cell membranes of responder and nonresponder mice.

  1995cites this paper
• Peptide binding to surface class II molecules is the major pathway of formation of immunogenic class II-peptide complexes for viable antigen presenting cells.

  1994cites this paper
• Cellular mechanisms of exogenous peptide binding to HLA class II molecules in B cells.

  1994cites this paper
• DQA1 and DQB1 genes in patients with squamous cell carcinoma of the cervix: relationship to human papillomavirus infection and prognosis.

  1994cites this paper
• Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides.

  1994cites this paper
• Direct binding of myelin basic protein and synthetic copolymer 1 to class II major histocompatibility complex molecules on living antigen-presenting cells--specificity and promiscuity.

  1994cites this paper
• Lack of binding of peptides carrying the human platelet antigen 1 (HPA-1) dimorphism to purified HLA-DRw52a molecules.

  1993cites this paper
• House dust mite allergy: from T‐cell epitopes to immuno‐therapy

  1993cites this paper
• Evidence for cobinding of self- and allopeptides to human class II major histocompatibility antigen DR1 by energy transfer.

  1993cites this paper
• Peptide binding to major histocompatibility complex molecules.

  1993cites this paper
• Self-peptides from four HLA-DR alleles share hydrophobic anchor residues near the NH2-terminal including proline as a stop signal for trimming.

  1993cites this paper
• Population genetics of rheumatoid arthritis.

  1992cites this paper
• pH dependence and exchange of high and low responder peptides binding to a class II MHC molecule.

  1992cites this paper
• Genetic control of nonresponsiveness to hepatitis B virus vaccine by an extended HLA haplotype

  1992cites this paper
• The human class II MHC protein HLA-DR1 assembles as empty alpha beta heterodimers in the absence of antigenic peptide.

  1992cites this paper
• In vitro maximum binding of antigenic peptides to murine MHC class II molecules does not always take place at the acidic pH of the in vivo endosomal compartment.

  1992cites this paper
• Antigen processing and presentation: close encounters in the endocytic pathway.

  1992cites this paper
• Binding of a major T cell epitope of mycobacteria to a specific pocket within HLA‐DRw17(DR3) molecules

  1992cites this paper
• Peptide-MHC interaction in autoimmunity.

  1992cites this paper
• Antibody binding to a collagen type‐II epitope gives rise to an inhibitory peptide for autoreactive T cells

  1992cites this paper
• The human class II MHC protein HLA-DR1 assembles as empty αβ heterodimers in the absence of antigenic peptide

  1992cites this paper
• Chemical and functional analysis of MHC class II-restricted T cell epitopes.

  1991cites this paper
• The cell biology of antigen processing.

  1991cites this paper
• Viral antibody titers, immunogenetic markers, and their interrelations in multiple sclerosis patients and controls

  1991cites this paper
• Peptide binding to class I MHC on living cells and quantitation of complexes required for CTL lysis

  1991cites this paper
• Interactions between immunogenic peptides and MHC proteins.

  1991cites this paper
• Analysis of the permissive association of a malaria T cell epitope with DR molecules.

  1991cites this paper
• The Dialectical Self: Immunology’s Contribution

  1991cites this paper
• Processed antigen binds to newly synthesized MHC class II molecules in antigen-specific B lymphocytes.

  1991cites this paper
• An in vitro model of peptide-mediated immunomodulation of the human T cell response to Dermatophagoides spp (house dust mite).

  1991cites this paper
• The cell biology of antigen processing and presentation.

  1991cites this paper
• Antibody recognition of an immunogenic influenza hemagglutinin-human leukocyte antigen class II complex

  1991cites this paper
• A monoclonal antibody specific for a cytochrome c T cell stimulatory peptide inhibits T cell responses and affects the way the peptide associates with antigen‐presenting cells

  1991cites this paper
• Non-radioactive detection of MHC class II-peptide antigen complexes in the sub-picomole range by high-performance size-exclusion chromatography with fluorescence detection.

  1991cites this paper
• Genetic control of immune response and disease susceptibility by the HLA-DQ gene.

  1991cites this paper
• Truncation analysis of several DR binding epitopes.

  1991cites this paper
• Cellular Mechanisms of Artificial Peptides Binding to HLA

  1991cites this paper
• Interactions between Immunogenic Peptides and MHC Proteins

  1991cites this paper
• An analysis of synthetic peptide restriction by HLA-DR alleles in T cells from human subjects, naturally sensitized by Streptococcus mutans.

  1991cites this paper
• Fluorescence and CD-spectrometric use of specifically labeled peptide antigens interacting with HLA-DR 1

  1991cites this paper
• The human leukocyte antigen (HLA) system: 1990.

  1990cites this paper
• Receptor-mediated antigen uptake and its effect on antigen presentation to class II-restricted T lymphocytes.

  1990cites this paper
• [The HLA system and rheumatoid arthritis].

  1990cites this paper
• Class II MHC molecules are spontaneously internalized in acidic endosomes by activated B cells.

  1990cites this paper
• Preparation and utilization of fluorescent synthetic peptides.

  1990cites this paper
• Prediction and identification of a T cell epitope in the fusion protein of measles virus immunodominant in mice and humans.

  1990cites this paper
• Detection of peptide-MHC class II complexes on the surface of intact cells.

  1990cites this paper
• Antigen Recognition and Peptide‐Mediated Immunotherapy in Autoimmune Disease

  1990cites this paper
• Transfection of genes for cell surface products involved in antigen presentation--applications to the understanding of autoimmunity.

  1990cites this paper
• Phospholipids enhance the binding of peptides to class II major histocompatibility molecules.

  1990cites this paper
• Interactions between immunogenic peptides and HLA-DR molecules

  1990cites this paper
• Characterization of the specificity of peptide binding to four DR haplotypes.

  1990cites this paper
• Regulation of antigen presentation by acidic pH

  1990cites this paper
• Degenerate binding of immunogenic peptides to HLA-DR proteins on B cell surfaces.

  1990cites this paper
• Cycling of cell-surface MHC glycoproteins through primaquine-sensitive intracellular compartments

  1990cites this paper
• HLA-linked Immune suppression genes

  1990cites this paper
• Peptides recognized by class I restricted T cells also bind to MHC class II molecules.

  1990cites this paper
• High-affinity binding of an influenza hemagglutinin-derived peptide to purified HLA-DR.

  1990cites this paper
• High Degeneracy of HLA DR-Peptide Interactions: Possible Ramifications for Vaccine Design

  1989cites this paper